CanadaBis Capital Inc. (CNADF)
OTCMKTS
· Delayed Price · Currency is USD
0.0625
-0.0005 (-0.79%)
At close: Apr 10, 2025
CanadaBis Capital Revenue
CanadaBis Capital had revenue of 4.91M CAD in the quarter ending January 31, 2025, with 13.86% growth. This brings the company's revenue in the last twelve months to 17.89M, down -14.41% year-over-year. In the fiscal year ending July 31, 2024, CanadaBis Capital had annual revenue of 17.95M, down -19.20%.
Revenue (ttm)
17.89M CAD
Revenue Growth
-14.41%
P/S Ratio
0.76
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.46M USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| SS Innovations International | 20.65M |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| Glass House Brands | 200.90M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |